Method for preparing and refining 1,3-propanedisulfonate
Patent Information
- Authority / Receiving Office
- CN ยท China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- NINGBO INST OF TECH ZHEJIANG UNIV ZHEJIANG
- Publication Date
- 2011-04-06
- Estimated Expiration
- Not applicable ยท inactive patent
Smart Images

Figure 1
Abstract
Description
[0001] technical field
[0002] The invention relates to the field of pharmaceutical chemical synthesis, in particular to a method for preparing and refining sodium 1,3-propanedisulfonate. Background of the invention
[0003] US Patent US5643562 discloses that 1,3-propanedisulfonate can be used to treat amyloidosis, and world patent WO2007125385 discloses that 1,3-propanedisulfonate can also be used to treat nephropathy, diabetic nephropathy and dyslipidemia. In fact, abroad, sodium 1,3-propanedisulfonate has entered phase III clinical trials for the treatment of amyloidosis, and phase II clinical trials for the treatment of diabetes. Will be available for sale soon.
[0004] The synthesis of 1,3-propanedisulfonate sodium was reported as early as the 1930s, and the literature [J.Am.Chem.Soc.1936; 58: 488-9] synthesized 1,3-propanedisulfonate sodium is to react 1,3-dibromopropane with sodium sulfite:
[0005]
[0006] Repeated treatment with lead acetate, silver nitrate...